Skip to main content

Original Research

Original Research
Perspectives of Quality Care in Cancer Treatment: A Review of the Literature
Lisa M. Hess, PhD, Gerhardt Pohl, PhD
Stakeholder Perspective
Quality of Cancer Care: Emerging Definition and Measurements, but Reimbursement Lagging
by Craig K. Deligdish, MD
Read More
Original Research
Burden of Disease: The Psychosocial Impact of Rosacea on a Patient’s Quality of Life
Tu T. Huynh, PhD
Stakeholder Perspective
The Psychosocial Impact of Skin Disorders: Time for a Closer Look?
by Matthew Mitchell, PharmD, MBA, FAMCP
Read More
Dermatology, Original Research
Burden of Disease: The Psychosocial Impact of Rosacea on a Patient’s Quality of Life
Tu T. Huynh, PhD
Stakeholder Perspective
The Psychosocial Impact of Skin Disorders: Time for a Closer Look?
by Matthew Mitchell, PharmD, MBA, FAMCP
Read More
Original Research
Patient-Reported Outcomes Are Changing the Landscape in Oncology Care: Challenges and Opportunities for Payers
Erin A. Zagadailov, PharmD, MS, Michael Fine, MD, Alan Shields, PhD
Stakeholder Perspective
Assessing the Value of Patient-Reported Outcomes
by Matthew Mitchell, PharmD, MBA, FAMCP
Read More
Original Research
Opioid Utilization Patterns Among Medicare Patients with Diabetic Peripheral Neuropathy
Jacqueline Pesa, PhD, MPH, Roxanne Meyer, PharmD, Tiffany P. Quock, MS, PhD, Stacy K. Rattana, RN, BSN, Samir H. Mody, PharmD, MBA
Stakeholder Perspective
Monitoring for Aberrant Opioid Utilization Patterns a Growing Need in Managed Care
by Curtis Wander, PharmD
Read More
Original Research
Effectiveness and Costs of TNF-Alpha Blocker Use for Patients with Rheumatoid Arthritis
Kavita Nair, PhD, Vahram Ghushchyan, PhD, Ahmad Naim, MD
Stakeholder Perspective
Assessing the Value of TNF-Alpha Blockers for Patients with Rheumatoid Arthritis
by Michael S. Jacobs, RPh
Read More
Original Research
National Burden of Preventable Adverse Drug Events Associated with Inpatient Injectable Medications: Healthcare and Medical Professional Liability Costs
Betsy J Lahue, MPH, Bruce S. Pyenson, FSA, MAAA, Kosuke Iwasaki, FIAJ, MAAA, Helen Blumen, MD, MBA, Susan Forray, FCAS, MAAA, Jeffrey M. Rothschild, MD, MPH
Stakeholder Perspective
by Jaan Sidorov, MD, MHSA
Read More
Original Research
Assessment of Treatment Patterns and Patient Outcomes in Levodopa-Induced Dyskinesias (ASTROID): A US Chart Review Study
Barbara Lennert, RN, BSN, MAOM, Wendy Bibeau, PhD, Eileen Farrelly, MPH, Patricia Sacco, MPH, RPh, Tessa Schoor, MD
Stakeholder Perspective
Parkinson’s Disease: A Complicated but Underappreciated and Undertreated Condition
by Gary M. Owens, MD
Read More
Original Research
Anticoagulant Use for Prevention of Stroke in a Commercial Population with Atrial Fibrillation
Aarti A. Patel, PharmD, MBA, Barbara Lennert, RN, BSN, MAOM, Brian Macomson, PharmD, Winnie W. Nelson, PharmD, Gary M. Owens, MD, Samir H. Mody, PharmD, MBA, Jeff Schein, DrPH, MPH
Stakeholder Perspective
The Enormous Impact of Atrial Fibrillation and Stroke on Patients, Payers, and Society
by Jack E. Fincham, PhD, RPh
Read More
Original Research
Conceptual and Analytical Considerations toward the Use of Patient-Reported Outcomes in Personalized Medicine
Demissie Alemayehu, PhD, Joseph C. Cappelleri, PhD
Stakeholder Perspective
No Physician Treats an Average Patient: Bridging the Gap between Group-Based Data and Patient-Specific Treatment Outcomes
by Michael F. Murphy, MD, PhD
Read More
Page 16 of 21
Results 151 - 160 of 209